United States· US:55154-8096_a34c0ed1-d697-4c6e-b211-a273cfbeeed5
Lisinopril
A lisinopril product containing lisinopril, registered in United States by Cardinal Health 107, LLC. The same ATC class is registered in 18 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Lisinopril is registered in 18 of 19 countries.
Countries holding a registration under ATC C09AA03 (lisinopril), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 10 of them publish a price we can compare per daily dose
Lisinopril · ATC C09AA03
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of lisinopril costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.086 in France to $0.36 in Switzerland — a ×4.1 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Lisinopril · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.36
- IT Italy$0.27
- ES Spain$0.13
- FR France$0.086
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- LISINOPRIL
- Manufacturer
- Cardinal Health 107, LLC
- Country
- United States (US)
- ATC code
- C09AA03
- ATC class
- Lisinopril
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 20, 2026
Packs & prices · 2
- ndc11551548096010 BLISTER PACK in 1 BAG (55154-8096-0) / 1 TABLET in 1 BLISTER PACK
- ndc1155154-8096-0
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
487 interactions on record for lisinopril.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lisinopril · interactions on record
487 records
- 11 severe
- 165 moderate
- 20 minor
- 215 info
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium gluconateA12BA05severe
- Potassium chlorideB05XA01severe
76 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Lisinopril in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCarace 5mg tabletsBristol-Myers Squibb Pharmaceuticals Ltd
- ItalyALAPRILNEOPHARMED GENTILI S.P.A.
- FinlandCardiostadSTADA Arzneimittel AG
- SwitzerlandLisinopril axapharm 5 mg, Tablettenaxapharm ag
- SpainDONEKA 5 mg COMPRIMIDOSNeuraxpharm Spain S.L.U.
- PolandLisiHEXAL 5Sandoz GmbH
- CanadaAPO-LISINOPRILAPOTEX INC
- IrelandLisinopril Grindeks 5 mg tabletsAS Grindeks
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Acemin, Acetan
- Belgium · Lisinopril Eg, Lisinopril Grindeks
- Bulgaria · Витоприл, Диротон
- Cyprus · Albigone, Dapril
- Czechia · Dapril, Diroton
- Germany · Lino, Lisi
- Denmark · Cardiostad, Lisinopril Actavis
- Estonia · Lisinopril Grindek,s, Lisinopril Grindeks
- Spain · Doneka, Lisinopril Aurovitas
- Finland · Cardiostad, Lisinopril Grindeks
- France · Lisinopril Arrow, Lisinopril Arrow Lab
- United Kingdom (Northern Ireland) · Lisinopril, Lisinopril Accord-Uk
- Greece · Adicanil, Leruze
- Croatia · Amicor, Irumed
- Hungary · Lisinopril Grindeks, Lisopress
- Ireland · Lestace, Lisinopril Grindeks
- Italy · Alapril, Lisinopril Aurobindo
- Lithuania · Diroton
- Luxembourg · Lisinopril Eg, Lisinopril Ratiopharm
- Latvia · Lisinopril Grindeks
- Malta · Dapril, Lisinopril Accord Healthcare
- Netherlands · Lisinopril Accord, Lisinopril Aurobindo
- Norway · Lisinopril Ratiopharm, Lisinopril Taw Pharma
- Poland · Lisihexal, Lisinopril Aurovitas
- Portugal · Ecapril, Lipril
- Romania · Lisinopril Atb, Lisinopril Sandoz
- Sweden · Lisiliv, Lisinopril Actavis
- Slovenia · Irumed, Skopryl
- Slovakia · Dapril, Diroton
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/da46a815-cd21-4e23-b8e2-f6e1e93298aa GET /v1/drugs/da46a815-cd21-4e23-b8e2-f6e1e93298aa?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "5",
"substance": "LISINOPRIL",
"productndc": "55154-8096",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA077321",
"marketing_category": "ANDA"
}See everything about lisinopril.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.